This study focused on common clinical inflammatory markers, including NLR, CLR, SII, CRP, FIB, PLR, HCY, and WBC and ultimately validated the utility of the NLR as a reliable prognostic indicator for AIS patients. The gene discussed is CRP; the disease is androgen insensitivity syndrome.